Trump activates tariffs on medications and forces pharmaceutical companies to choose between paying more or moving to the country
Las grandes compañías europeas pagarán gravámenes del 15% para exportar a Estados Unidos
The Donald Trump administration has moved from threat to action. The United States began applying tariffs this Friday to patented medicines and imported active ingredients under Section 232 of the Trade Expansion Act, a tool reserved for sectors considered strategic for national security. The measure affects the large pharmaceutical companies included in Annex III of the executive order and makes the sector one of the new fronts of Washington's commercial offensive.
For the rest of the companies not on this list, the measure will start being applied as of September 29. The products listed in this section are exempt from the fees announced last week under the forced labor investigation, which avoids a double penalty.
Translated by urgent.news. Machine-written — may contain errors; check the original before relying on it.
